5,364
Participants
Start Date
September 30, 2006
Primary Completion Date
May 31, 2009
Study Completion Date
June 30, 2010
Cangrelor
cangrelor bolus (30 mcg/kg) \& cangrelor infusion (4 mcg/kg/min) administered from randomization for at least 2 hours, or until the end of the PCI, whichever is longer with the option to extend up to 4 hours maximum (per investigator discretion)
clopidogrel
clopidogrel capsules (600 mg) at end of PCI
Placebo bolus & placebo infusion
placebo bolus (30 mcg/kg) \& placebo infusion (4 mcg/kg/min) administered from randomization for at least 2 hours, or until the end of the PCI, whichever is longer with the option to extend up to 4 hours maximum (per investigator discretion)
Placebo capsules - end of PCI
Placebo capsules given at the end of PCI to mimic 600mg clopidogrel dosing
Placebo capsules - end of infusion
Placebo capsules given at the end of infusion to mimic 600mg clopidogrel dosing
Innovis Health, Fargo
Lead Sponsor
The Medicines Company
INDUSTRY